# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000805928-22-000051
Filing Date
2022-04-14
Accepted
2022-04-14 16:34:08
Documents
9
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | axgn_proxyx20211.htm | DEF 14A | 1187442
2 |  | cardbw2a.jpg | GRAPHIC | 74873
3 |  | cardbwa.jpg | GRAPHIC | 121601
4 |  | cardcolor1a.jpg | GRAPHIC | 96474
5 |  | cardcolor2a.jpg | GRAPHIC | 75606
6 |  | chart-432428836b954696b27a.jpg | GRAPHIC | 64349
7 |  | image_0a.jpg | GRAPHIC | 48557
8 |  | image_1a.jpg | GRAPHIC | 10908
9 |  | image_2a.jpg | GRAPHIC | 44886
| Complete submission text file | 0000805928-22-000051.txt |  | 1923997

Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36046 | Film No.: 22827716
SIC: 3845 Electromedical & Electrotherapeutic Apparatus